Pharmaceutical industry news

Ubiquitin marks abnormal glycogen for destruction to protect the brain

AbbVie Named Official Pharmaceutical Sponsor of the PGA TOUR and 2026 Presidents Cup, Launches Birdies for Brain Health Campaign

AbbVie and BioLabs University of Toronto Open Applications for AbbVie Biotech Innovators Award at Life Sciences Ontario Forum

UK Advisory Panel (UKAP): enquiry form

Enquiry form to send to the UK Advisory Panel for Healthcare Workers Living with Bloodborne Viruses...

Imvax Announces Additional Data from Phase 2b Clinical Trial of IGV-001 in Newly Diagnosed GBM and Provides Update on Planned Clinical Development

The biotech industry wrote Montana's right-to-try law. Now they're running the show.

Intermountain Health Primary Children's Hospitals Once Again Ranked Among Nation's Best in All 11 Pediatric Specialties by U.S. News & World Report

New Haven biotech raises $33M for cancer drug development

FDA Hears 80 Speakers on Psychedelic Drug Therapy Standards

Scientists discover a major brain shift between ages 50 and 75

AbbVie and BioLabs University of Toronto Open Applications for AbbVie Biotech Innovators Award at Life Sciences Ontario Forum

Agentic AI trust gap slowing healthcare provider adoption, survey reveals

GSK to acquire potential best-in-class T cell-engager (TCE) for multiple myeloma from Chimagen Biosciences

Supporting Complex Phase I Studies Through Integrated Imaging and Specialized Assessments

Defining AD Disease Flares vs Drug Effects: A Comparative Analysis of Phase 3 Systemic Therapy Trials

Stakeholders urge FDA to define data, treatment standards as psychedelic drugs near market

Rare disease reform, CMC risk, reshoring US trials top of mind ahead of PDUFA VIII meeting

R1-32-like public antibodies acquire tolerance to SARS-CoV-2 antigenic drift through somatic hypermutation

Does acute inflammation triggered by infection promote cancer progression?

Cyclic tri-adenylate controls a CARF-TM effector in type II Panoptes anti-phage systems

Atlastin-2-mediated endoplasmic reticulum membrane tethering is critical for flavivirus replication

Connect's Dupixent rival flunks phase 2 asthma trial, but biotech sees reasons for hope

Obesity drugmakers are testing in kids as young as 6

FDA psychedelics hearing tackles questions about treatments

Despite 3 patient deaths, Cullinan-Taiho plan FDA filing for lung cancer pill on survival benefit

How New Drug Trial Approvals At CSPC Pharmaceutical Group Stock Has Changed Its Investment Story

Weekly all-cause mortality surveillance: week ending 11 October 2026

How the actual number of deaths in England compare with expected numbers for each week.

National Norovirus and Rotavirus Report, week 42 report: data to week 41 (data up to 11 October 2026)

Summary of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in England du...

National flu and COVID-19 surveillance report, week 42 report: data to week 41 (data up to 11 October 2026)

National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasona...

Legend Biotech taps Novartis veteran Zhang as CEO

Kelun-Biotech reports Phase III benefit for trastuzumab botidotin in HER2-positive breast cancer

Scholar Rock clarifies post-marketing requirements for ISEMBYLD after FDA approval

Legend Biotech Corporation Announces CEO Changes

The Overlooked Science of eCOA: When Good Clinical Outcome Assessments Still Produce Poor Data

More than 320 pain professionals attended Ensysce’s symposium on complex pain.

National Cancer Plan for England

Details the government’s plan to transform cancer care and outcomes in England by 2035.

What 340B Rebate Tracking Really Demands From Pharmacies

ACTO Named Among Everest Group’s Top 50™ Pharmaceutical Technology Providers for 2026

FDA held a public hearing on psychedelic therapies as Trump's push to speed approvals gathered pace

How Can Focused Ultrasound Treat Tremor and Movement Symptoms in Parkinson’s Disease?

What Americans Really Want from Drug Ads

FDA Accepts Curi Bio’s Letter of Intent into ISTAND Program to Qualify 3D Neuromuscular Junction Assay as a Non-Animal Replacement for Botulinum Toxin Potency Testing

Legend Names Novartis Executive as CEO

‘They had a plan’: How Sophia’s parents found care for ROHHAD syndrome

UK Covid-19 Inquiry

Module reports, government responses, implementation dashboard and costs of responding to the UK Cov...

Scholar Rock clarifies post-marketing requirements for ISEMBYLD after FDA approval

HAS Group announces Swissmedic approval of Cerbios’ expanded Reduced Folates Production Unit

Legend Biotech taps Novartis veteran Zhang as CEO

Co-Creating an Individual Data Return Template: A Patient-Centered Approach by CISCRP and Biogen

Lilly pledges up to $237M per program in CNS genetic med collab with Canadian biotech

Canaccord raises Definium Therapeutics price target on trial results

Survey: Adults With Multiple or Complex Health Conditions Face Significant Challenges with Health Costs and Commonly Struggle to Access Care

Health Care Access and Affordability for Adults with Multiple or Complex Health Conditions: A Snapshot of Patient Experiences

AbbVie Named Official Pharmaceutical Sponsor of the PGA TOUR and 2026 Presidents Cup, Launches Birdies for Brain Health Campaign

Vaccination of people with uncertain or incomplete immunisation

Summary for health professionals and immunisation practitioners giving vaccinations.

Let’s talk with Sorrisi in Rosa: 10 anni insieme

MAIA Biotechnology Announces Insider Share Purchases by Board Member and CEO Amid Positive Phase 3 and Phase 2 Data Updates

La AEMPS habilita una nueva aplicación para presentar telemáticamente la declaración responsable de actividades de fabricación y/o importación de productos de cuidado personal

Compass Pathways Just Answered the Durability Question. Now Comes the Harder Problem.

NKGen Biotech to Present on Troculeucel for